Evaluation of Haemophilus influenzae Type B Conjugate Vaccine (Meningococcal Protein Conjugate) in Canadian Infants

David W Scheifele; Gordean L Bjornson; William G Meekison; Roland Guasparini; Leslie A Mitchell

doi:10.1155/1994/479313

Canadian Journal of Infectious Diseases (Jan 1994)

Evaluation of Haemophilus influenzae Type B Conjugate Vaccine (Meningococcal Protein Conjugate) in Canadian Infants

David W Scheifele,
Gordean L Bjornson,
William G Meekison,
Roland Guasparini,
Leslie A Mitchell

Affiliations

David W Scheifele: Vaccine Evaluation Center, BC’s Children’s Hospital and the University of British Columbia, Vancouver, Canada
Gordean L Bjornson: Vaccine Evaluation Center, BC’s Children’s Hospital and the University of British Columbia, Vancouver, Canada
William G Meekison: Vaccine Evaluation Center, BC’s Children’s Hospital and the University of British Columbia, Vancouver, Canada
Roland Guasparini: Vaccine Evaluation Center, BC’s Children’s Hospital and the University of British Columbia, Vancouver, Canada
Leslie A Mitchell: Vaccine Evaluation Center, BC’s Children’s Hospital and the University of British Columbia, Vancouver, Canada

DOI: https://doi.org/10.1155/1994/479313
Journal volume & issue: Vol. 5, no. 2
pp. 75 – 81

Abstract

Read online

Objective: To assess adverse effects and immune responses with a three-dose series of Haemophilus influenzae type b meningococcal protein conjugate (PedvaxHIB or Hib.OMP) vaccine, including any immunological response alterations from concurrent administration with routine vaccines for infants.

Published in Canadian Journal of Infectious Diseases

ISSN: 1180-2332 (Print)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Infectious and parasitic diseases
Website: https://onlinelibrary.wiley.com/journal/9575

About the journal